Clinical Trial Update: Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of GZR101-80 Injection in adults with Type 2 diabetes; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GZR101-80 Injection

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Type 2 Diabetes (T2DM) | Phase 2 | Status: NOT_YET_RECRUITING